These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 5067718)
1. Teratogenic drug screening. Present procedures and requirements. Tuchmann-Duplessis H Teratology; 1972 Jun; 5(3):271-85. PubMed ID: 5067718 [No Abstract] [Full Text] [Related]
2. Toxicological investigations of 4,5-diphenyl-2-bis(2-hydroxyethyl)-aminoxazol (ditazol or S 222). Caprino L; Borrelli F; Falchetti R Arzneimittelforschung; 1973 Sep; 23(9):1287-91. PubMed ID: 4801222 [No Abstract] [Full Text] [Related]
3. [Present position of the toxicology of drugs]. Frohberg H Munch Med Wochenschr; 1970 Aug; 112(35):1532-43. PubMed ID: 4990080 [No Abstract] [Full Text] [Related]
4. [The influence of butylmalonic acidmono-(1,2-diphenylhydrazide)-calcium (bumadizone-calcium) on reproduction and prenatal development]. König J; Knoche C; Schäfer H Arzneimittelforschung; 1973 Sep; 23(9):1246-51. PubMed ID: 4801217 [No Abstract] [Full Text] [Related]
5. [Fetal damage by drugs in animal experiments (prenatal toxicology-a new branch of experimental research)]. von Kreybig T Hippokrates; 1969 Mar; 40(6):201-9. PubMed ID: 5802153 [No Abstract] [Full Text] [Related]
7. Problems associated with the screening of drugs for possible teratogenic activity. Palmer AK Exp Embryol Teratol; 1974; 1(0):16-33. PubMed ID: 4464051 [No Abstract] [Full Text] [Related]
8. Drug toxicity in the animal fetus. McColl JD Appl Ther; 1967 Nov; 9(11):915-7. PubMed ID: 4964963 [No Abstract] [Full Text] [Related]
9. The influence of xyloxemine hydrochloride, 2-[2-(DI-2,6-xylylmethoxy)ethoxy]-N,N-dimethylethylamine hydrochloride, on reproduction in laboratory animals. van Eeken CJ; Mulder D Arch Int Pharmacodyn Ther; 1967 May; 167(1):135-41. PubMed ID: 6035090 [No Abstract] [Full Text] [Related]
11. [Role of pharmacokinetics in realizing the embryotoxic action of drugs]. Smol'nikova NM; Boĭko SS; Liubimov BI Farmakol Toksikol; 1986; 49(2):106-11. PubMed ID: 3519275 [No Abstract] [Full Text] [Related]
12. Application of metabolic data to the evaluation of drugs. A report prepared by the committee on problems of drug safety of the drug research board, National Academy of Sciences-National Research Council. Clin Pharmacol Ther; 1969; 10(5):607-34. PubMed ID: 4980111 [No Abstract] [Full Text] [Related]
13. [The basic methodological approaches to testing the teratogenic activity of chemical substances]. Dyban AP; Baranov VS; Akimova IM Arkh Anat Gistol Embriol; 1970; 59(10):89-100. PubMed ID: 5511190 [No Abstract] [Full Text] [Related]
14. Researchers exploring faster alternatives to 2-year test for carcinogenicity. Schmidt C J Natl Cancer Inst; 2006 Feb; 98(4):228-30. PubMed ID: 16478737 [No Abstract] [Full Text] [Related]
15. [Toxicology of the antileprosy drug 3-(para-chloranilino)-10-(para-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazine (G 30 320). Acute and subchronic toxicity, reproduction toxicology]. Stenger EG; Aeppli L; Peheim E; Thomann PE Arzneimittelforschung; 1970 Jun; 20(6):794-9. PubMed ID: 4989740 [No Abstract] [Full Text] [Related]
16. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits. Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480 [TBL] [Abstract][Full Text] [Related]
18. [Species differences in the metabolism of drugs]. Sjöqvist F Nord Med; 1967 Oct; 78(42):1364. PubMed ID: 5590749 [No Abstract] [Full Text] [Related]
19. [Primates in studies on the safety of drugs]. Verschuere B; Collin A; Landsmann F; Fabre G; Famose F; Gouy D Pathol Biol (Paris); 1990 Mar; 38(3):221-4. PubMed ID: 2186341 [TBL] [Abstract][Full Text] [Related]